ProMIS Neurosciences Inc PMN

New Press Release - ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer's Disease

TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 08, 2023 (GLOBE NEWSWIRE) -- In preclinical studies, PMN310 demonstrated theability to selectively target and protect against pathogenic Aß oligomersThe IND clearance of PMN310 in the Alzheimer’s disease indication paves the way for initiation of...read article.

[G1945V]

"With the IND clearance for PMN310, the Company plans to initiate a Phase 1a clinical trial designed to evaluate the pharmacokinetics, safety and tolerability of a range of PMN310 doses in healthy adult volunteers." But WHEN! G1945V

[M101]

"When?" Exactly, nothing says wait for the other shoe to drop (financing) quite like not hearing the other shoe drop (when). 

[bball67]

My conjecture is it will be in 2-3 months, when 1a trial is completed, thus clearing the deck for an offering. At that point the stock should have built a good base at a slightly higher level than now. Don't assume that an offering would be at lower levels. There could be a 10x demand for the stock which drives the price up, like an IPO. The Boston group will put in $10M or possibly more and

[G1945V]

An offering better be at a level of a lot more than $30M. And the Boston Group owning a 50%+ of ProMis. I can't see that with only putting in $10M. And you wouldn't what them owning a majority interest in the stock. I'm also in the conjecture territory. :) G1945V